Allscripts 'evaluating strategic alternatives'

| | Health Exec | Digital Transformation

Allscripts Healthcare Solutions is evaluating strategic alternatives, according to a statement from CEO Glen Tullman.

"We are confirming today that in light of the ongoing interest expressed in the company by third parties, the company is evaluating strategic alternatives,” Tullman said in a release.  The company further stated that there could be no assurance that this process will result in any specific transaction and Allscripts does not intend to comment further publicly with respect to the evaluation of strategic alternatives unless a specific transaction is approved by its board. 

Allscripts also released its third quarter financial details which include a drop in bookings. The $161.9 million in bookings for this period compared with bookings of $266.8 million in the third quarter of 2011 and $194.1 million in the second quarter of 2012.

“While market uncertainty impacted our sales in the third quarter, we are pleased with our progress regarding important development initiatives,” said Tullman.

Related Content

AdvaMed itemizes AI imperatives for ‘the entire healthcare ecosystem’
6 things high-achieving orgs do to wring real value from AI
A modest proposal to rally AI regulators around a simple game plan
4 points crucial to the nimble regulation of GenAI
5 tips to learn AI from scratch and for free
Good AI governance can spell the difference between smashing success and mere learning experience

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup